164 related articles for article (PubMed ID: 24818884)
1. Bioactivity and circulation time of PEGylated NELL-1 in mice and the potential for osteoporosis therapy.
Zhang Y; Velasco O; Zhang X; Ting K; Soo C; Wu BM
Biomaterials; 2014 Aug; 35(24):6614-21. PubMed ID: 24818884
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and osteogenic potential of PEGylated NELL-1 in vivo after systemic administration.
Kwak JH; Zhang Y; Park J; Chen E; Shen J; Chawan C; Tanjaya J; Lee S; Zhang X; Wu BM; Ting K; Soo C
Biomaterials; 2015 Jul; 57():73-83. PubMed ID: 25913252
[TBL] [Abstract][Full Text] [Related]
3. Nell-1, a key functional mediator of Runx2, partially rescues calvarial defects in Runx2(+/-) mice.
Zhang X; Ting K; Bessette CM; Culiat CT; Sung SJ; Lee H; Chen F; Shen J; Wang JJ; Kuroda S; Soo C
J Bone Miner Res; 2011 Apr; 26(4):777-91. PubMed ID: 20939017
[TBL] [Abstract][Full Text] [Related]
4. The Effects of Systemic Therapy of PEGylated NEL-Like Protein 1 (NELL-1) on Fracture Healing in Mice.
Tanjaya J; Lord EL; Wang C; Zhang Y; Kim JK; Nguyen A; Baik L; Pan HC; Chen E; Kwak JH; Zhang X; Wu B; Soo C; Ting K
Am J Pathol; 2018 Mar; 188(3):715-727. PubMed ID: 29294300
[TBL] [Abstract][Full Text] [Related]
5. Nell-1 Enhances Osteogenic Differentiation of Pre-Osteoblasts on Titanium Surfaces via the MAPK-ERK Signaling Pathway.
Shen MJ; Wang GG; Wang YZ; Xie J; Ding X
Cell Physiol Biochem; 2018; 50(4):1522-1534. PubMed ID: 30359975
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Intraperitoneal Administration of PEGylated NELL-1 for Bone Formation.
Tanjaya J; Zhang Y; Lee S; Shi J; Chen E; Ang P; Zhang X; Tetradis S; Ting K; Wu B; Soo C; Kwak JH
Biores Open Access; 2016; 5(1):159-70. PubMed ID: 27354930
[TBL] [Abstract][Full Text] [Related]
7. Controlled release of NELL-1 protein from chitosan/hydroxyapatite-modified TCP particles.
Zhang Y; Dong R; Park Y; Bohner M; Zhang X; Ting K; Soo C; Wu BM
Int J Pharm; 2016 Sep; 511(1):79-89. PubMed ID: 27349789
[TBL] [Abstract][Full Text] [Related]
8. NELL-1 increases pre-osteoblast mineralization using both phosphate transporter Pit1 and Pit2.
Cowan CM; Zhang X; James AW; Kim TM; Sun N; Wu B; Ting K; Soo C
Biochem Biophys Res Commun; 2012 Jun; 422(3):351-7. PubMed ID: 22580275
[TBL] [Abstract][Full Text] [Related]
9. Synergistic effects of Nell-1 and BMP-2 on the osteogenic differentiation of myoblasts.
Cowan CM; Jiang X; Hsu T; Soo C; Zhang B; Wang JZ; Kuroda S; Wu B; Zhang Z; Zhang X; Ting K
J Bone Miner Res; 2007 Jun; 22(6):918-30. PubMed ID: 17352654
[TBL] [Abstract][Full Text] [Related]
10. NELL-1 in the treatment of osteoporotic bone loss.
James AW; Shen J; Zhang X; Asatrian G; Goyal R; Kwak JH; Jiang L; Bengs B; Culiat CT; Turner AS; Seim Iii HB; Wu BM; Lyons K; Adams JS; Ting K; Soo C
Nat Commun; 2015 Jun; 6():7362. PubMed ID: 26082355
[TBL] [Abstract][Full Text] [Related]
11. Bisphosphonate conjugation enhances the bone-specificity of NELL-1-based systemic therapy for spaceflight-induced bone loss in mice.
Ha P; Kwak JH; Zhang Y; Shi J; Tran L; Liu TP; Pan HC; Lee S; Kim JK; Chen E; Shirazi-Fard Y; Stodieck LS; Lin A; Zheng Z; Dong SN; Zhang X; Wu BM; Ting K; Soo C
NPJ Microgravity; 2023 Sep; 9(1):75. PubMed ID: 37723136
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, characterization and evaluation of bone targeting salmon calcitonin analogs in normal and osteoporotic rats.
Bhandari KH; Newa M; Chapman J; Doschak MR
J Control Release; 2012 Feb; 158(1):44-52. PubMed ID: 22001608
[TBL] [Abstract][Full Text] [Related]
13. Conjugation to 10 kDa Linear PEG Extends Serum Half-Life and Preserves the Receptor-Binding Ability of mmTRAIL with Minimal Stimulation of PEG-Specific Antibodies.
Nie Q; Jia D; Yang H; Feng Y; Fan Q; Shi Q; Wan L; Lu X
Mol Pharm; 2017 Feb; 14(2):502-512. PubMed ID: 28029256
[TBL] [Abstract][Full Text] [Related]
14. Eurycoma longifolia as a potential alternative to testosterone for the treatment of osteoporosis: Exploring time-mannered proliferative, differentiative and morphogenic modulation in osteoblasts.
Thu HE; Mohamed IN; Hussain Z; Shuid AN
J Ethnopharmacol; 2017 Jan; 195():143-158. PubMed ID: 27818256
[TBL] [Abstract][Full Text] [Related]
15. Proliferation and osteogenic differentiation of mesenchymal stem cells induced by a short isoform of NELL-1.
Pang S; Shen J; Liu Y; Chen F; Zheng Z; James AW; Hsu CY; Zhang H; Lee KS; Wang C; Li C; Chen X; Jia H; Zhang X; Soo C; Ting K
Stem Cells; 2015 Mar; 33(3):904-15. PubMed ID: 25376942
[TBL] [Abstract][Full Text] [Related]
16. Craniosynostosis in transgenic mice overexpressing Nell-1.
Zhang X; Kuroda S; Carpenter D; Nishimura I; Soo C; Moats R; Iida K; Wisner E; Hu FY; Miao S; Beanes S; Dang C; Vastardis H; Longaker M; Tanizawa K; Kanayama N; Saito N; Ting K
J Clin Invest; 2002 Sep; 110(6):861-70. PubMed ID: 12235118
[TBL] [Abstract][Full Text] [Related]
17. Neurexin Superfamily Cell Membrane Receptor Contactin-Associated Protein Like-4 (Cntnap4) Is Involved in Neural EGFL-Like 1 (Nell-1)-Responsive Osteogenesis.
Li C; Zheng Z; Ha P; Chen X; Jiang W; Sun S; Chen F; Asatrian G; Berthiaume EA; Kim JK; Chen EC; Pang S; Zhang X; Ting K; Soo C
J Bone Miner Res; 2018 Oct; 33(10):1813-1825. PubMed ID: 29905970
[TBL] [Abstract][Full Text] [Related]
18. Site-specific PEGylation of bone morphogenetic protein-2 cysteine analogues.
Hu J; Duppatla V; Harth S; Schmitz W; Sebald W
Bioconjug Chem; 2010 Oct; 21(10):1762-72. PubMed ID: 20886828
[TBL] [Abstract][Full Text] [Related]
19. NELL-1 binds to APR3 affecting human osteoblast proliferation and differentiation.
Zou X; Shen J; Chen F; Ting K; Zheng Z; Pang S; Zara JN; Adams JS; Soo C; Zhang X
FEBS Lett; 2011 Aug; 585(15):2410-8. PubMed ID: 21723284
[TBL] [Abstract][Full Text] [Related]
20. Nell-1-induced bone regeneration in calvarial defects.
Aghaloo T; Cowan CM; Chou YF; Zhang X; Lee H; Miao S; Hong N; Kuroda S; Wu B; Ting K; Soo C
Am J Pathol; 2006 Sep; 169(3):903-15. PubMed ID: 16936265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
